Advertisement
Screener

STREAMEX CORP. (STEX) Graph

STEX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $146.00K; Cost of revenue (m); Research and development (m); Operating expenses $15.31M.
  • 2026-03-31: Revenue $12.00K; Cost of revenue (m); Research and development (m); Operating expenses $35.75M.
  • 2025-12-31: Revenue (m); Cost of revenue (m); Research and development $0.00*; Operating expenses $41.63M*.
  • 2025-09-30: Revenue (m); Cost of revenue (m); Research and development $6.00K; Operating expenses $6.11M.

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

STEX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Corporate-$146.00KRevenue$146.00KOperating expenses$15.31MOperating income-$15.16MOther income, net$200.00KPre-tax income-$15.06MIncome tax-$505.00K

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$146.00K(m)(m)$15.31M-$505.00K-$14.55M
2026-03-31$12.00K(m)(m)$35.75M-$565.00K-$46.69M
2025-12-31(m)(m)$0.00*$41.63M*-$489.00K*-$424.01M*
2025-09-30(m)(m)$6.00K$6.11M-$765.00K-$15.58M
2025-06-30(m)(m)$19.00K$20.36M(m)-$20.37M
2025-03-31(m)(m)$6.00K$2.98M(m)-$2.81M
2024-09-30(m)(m)$156.00K$2.95M(m)-$1.91M
2024-06-30$13.00K(m)$342.00K$5.30M(m)-$3.92M
2024-03-31$14.00K(m)$238.00K$3.45M(m)-$3.40M
2023-09-30$1.00K(m)$1.15M$4.05M(m)-$4.57M
2023-06-30$0.00(m)$1.71M$10.91M$0.00-$11.09M
2023-03-31$5.00K(m)$1.06M$7.39M$0.00-$7.33M
2022-12-31(m)(m)(m)(m)$0.00*(m)
2022-09-30$135.00K$30.00K$1.73M$6.59M$0.00-$6.37M
2022-06-30$8.00K$0.00$1.35M$5.72M$0.00-$5.76M
2022-03-31$8.00K$0.00$1.62M$8.07M$0.00-$7.96M
2021-09-30$108.00K$38.00K$1.31M$7.87M$0.00-$7.25M
2021-06-30$207.00K$62.00K$1.67M$8.20M$0.00-$7.70M
2021-03-31$118.00K$99.00K$1.27M$8.58M$0.00-$8.32M
2020-09-30$0.00$0.00$4.91M$13.10M$0.00-$11.40M
2020-06-30$0.00$0.00$5.72M$22.35M$0.00-$19.19M
2020-03-31$0.00$0.00$4.93M$12.80M$0.00-$11.34M
2019-09-30(m)(m)$1.64M$5.50M$0.00-$5.44M
2019-06-30(m)(m)$1.82M$7.99M$0.00-$7.95M
2019-03-31(m)(m)$1.49M$5.88M$0.00-$5.88M
2018-09-30(m)(m)$744.17K$3.15M$0.00-$3.35M
2018-06-30(m)(m)$1.45M$5.77M$0.00-$5.77M
2018-03-31(m)(m)$862.42K$2.64M$0.00-$2.64M
2017-09-30(m)(m)$1.12M$1.91M$0.00-$1.80M
2017-06-30(m)(m)$1.34M$3.02M$0.00-$3.08M
2017-03-31(m)(m)$1.34M$2.90M$0.00-$3.27M
2016-09-30(m)(m)$560.51K$1.55M$0.00-$1.54M
2016-06-30(m)(m)$1.15M$5.54M$0.00-$6.09M
2016-03-31(m)(m)$372.43K$2.31M$0.00-$2.58M
2015-09-30(m)(m)$354.47K$2.47M$0.00$377.67K
2015-06-30(m)(m)$489.56K$4.43M$0.00-$4.76M
2015-03-31(m)(m)$302.08K$3.05M$0.00-$3.05M
2014-09-30(m)(m)$144.23K$3.94M$0.00-$3.96M
2014-06-30(m)(m)$99.89K$588.53K$0.00-$787.22K
2014-03-31(m)(m)$122.15K$728.15K$0.00-$1.12M
2013-09-30(m)(m)$289.96K$803.72K$0.00-$2.59M
2013-06-30(m)(m)$178.51K$1.22M$0.00-$1.84M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$146.00K(m)(m)$51.05M-$1.07M-$61.24M
2025-06-30(m)(m)$25.00K$23.35M(m)-$23.18M
2024-06-30$27.00K(m)$580.00K$8.76M(m)-$7.32M
2023-06-30$5.00K(m)$2.77M$18.30M$0.00-$18.43M
2022-06-30$16.00K$0.00$2.97M$13.80M$0.00-$13.72M
2021-06-30$325.00K$161.00K$2.93M$16.77M$0.00-$16.02M
2020-06-30(m)(m)$10.64M$35.15M$0.00-$30.52M
2019-06-30(m)(m)$3.31M$13.86M$0.00-$13.82M
2018-06-30(m)(m)$2.31M$8.40M$0.00-$8.40M
2017-06-30(m)(m)$2.68M$5.92M$0.00-$6.35M
2016-06-30(m)(m)$1.58M$7.85M$0.00-$8.68M
2015-06-30(m)(m)$791.64K$7.48M$0.00-$7.81M
2014-06-30(m)(m)$222.04K$1.32M$0.00-$1.90M
2013-06-30(m)(m)$484.85K$4.55M$0.00-$5.55M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30(m)(m)$31.00K$29.46M-$765.00K-$38.77M
2024-09-30$27.00K(m)$736.00K$11.71M(m)-$9.23M
2023-09-30$6.00K(m)$3.92M$22.35M(m)-$22.99M
2022-09-30$151.00K$30.00K$4.70M$20.39M$0.00-$20.09M
2021-09-30$433.00K$199.00K$4.25M$24.65M$0.00-$23.27M
2020-09-30$0.00$0.00$15.56M$48.25M$0.00-$41.93M
2019-09-30(m)(m)$4.95M$19.37M$0.00-$19.26M
2018-09-30(m)(m)$3.06M$11.56M$0.00-$12.34M
2017-09-30(m)(m)$3.80M$7.83M$0.00-$8.15M
2016-09-30(m)(m)$2.14M$9.41M$0.00-$10.21M
2015-09-30(m)(m)$1.15M$9.96M$0.00-$7.44M
2014-09-30(m)(m)$366.27K$5.26M$0.00-$5.86M
2013-09-30(m)(m)$774.81K$5.36M$0.00-$8.14M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31(m)(m)$31.00K$71.09M-$1.25M-$462.77M
2024-12-31$40.00K(m)$832.00K$12.90M$0.00-$10.33M
2023-12-31$18.00K(m)$5.09M$28.53M(m)-$29.04M
2022-12-31$286.00K$57.00K$5.82M$27.49M$0.00-$27.05M
2021-12-31$441.00K$199.00K$5.60M$33.65M$0.00-$31.92M
2020-12-31$0.00$0.00$18.14M$59.18M$0.00-$52.22M
2019-12-31(m)(m)$9.74M$34.60M$0.00-$34.05M
2018-12-31(m)(m)$4.37M$17.26M$0.00-$18.14M
2017-12-31(m)(m)$4.76M$12.91M$0.00-$12.70M
2016-12-31(m)(m)$2.65M$11.16M$0.00-$11.59M
2015-12-31(m)(m)$1.51M$12.04M$0.00-$9.46M
2014-12-31(m)(m)$1.51M$7.87M$0.00-$8.47M
2013-12-31(m)(m)$992.21K$6.24M$0.00-$9.80M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B